Cover
Cover | Dec. 21, 2023 |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Amendment No. 2 (“Amendment No. 2”) to the Current Report on Form 8-K is being filed as the second amendment to the Current Report on Form 8-K (the “Amended Form 8-K”) filed by Tenon Medical, Inc. (the “Company”) on December 26, 2023 as amended by Amendment No. 1 thereto filed on January 11, 2023. The sole purpose of this Amendment No. 2 is to supplement the disclosure in the Amended Form 8-K with details of the special meeting of the Company’s stockholders held on January 30, 2024 that was held after the adjournment of the special meetings of the Company’s stockholders held on December 21, 2023 and January 8, 2024. This Amendment No. 2 does not otherwise change or update the disclosure set forth in the Amended Form 8-K and does not otherwise reflect events after the Amended Form 8-K. |
Document Period End Date | Dec. 21, 2023 |
Entity File Number | 001-41364 |
Entity Registrant Name | TENON MEDICAL, INC. |
Entity Central Index Key | 0001560293 |
Entity Tax Identification Number | 45-5574718 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 104 Cooper Court |
Entity Address, City or Town | Los Gatos |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 95032 |
City Area Code | 408 |
Local Phone Number | 649-5760 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Common Stock, par value $0.001 per share | |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | TNON |
Security Exchange Name | NASDAQ |
Warrants | |
Title of 12(b) Security | Warrants |
Trading Symbol | TNONW |
Security Exchange Name | NASDAQ |